Alembic Pharmaceuticals Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 1,882.10 | 1,744.62 | 1,652.97 |
| Operating Expense | 1,522.24 | 1,469.43 | 1,412.87 |
| Net Profit | 196.96 | 243.07 | 114.47 |
| Net Profit Margin | 10.46% | 13.93% | 6.93% |
| Earning Per Share | 10.02 | 12.37 | 5.82 |
| EBIDTA | 344.25 | 376.64 | 240.10 |
| Effective Tax Rate | 12.04% | 11.57% | 10.12% |
Particulars
Jun 2026
Revenue1,882.10
Operating Expense1,522.24
Net Profit196.96
Net Profit Margin10.46
Earning Per Share10.02
EBIDTA344.25
Effective Tax Rate12.04
